Langerhans cell precursors acquire RANK/CD265 in prenatal human skin

Acta Histochemica

Volumn 117, Issue 4-5, 2015, Pages 425-430

  Schöppl, Alice ^a   Botta, Albert ^a   Prior, Marion ^a   Akgün, Johnnie ^a,b   Schuster, Christopher ^a   Elbe Bürger, Adelheid ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Development; Langerhans cells; Precursor; Prenatal; RANK; Skin

Indexed keywords

RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN;

ADULT; ARTICLE; CELL POPULATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; FETUS; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LANGERHANS CELL; NORMAL HUMAN; PRENATAL PERIOD; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; SKIN; BIOSYNTHESIS; CYTOLOGY; EMBRYOLOGY; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; PHYSIOLOGY; STEM CELL;

ADULT; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LANGERHANS CELLS; MALE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SKIN; STEM CELLS;

EID: 84930542980     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2015.01.003     Document Type: Article

References (27)

1. Akgün J. Differential expression of RANK on Langerhans cells and CD45RA and CD45RO/CLA on T cells in developing human skin after birth 2010, University of Vienna, Diploma Thesis.
2. Arizon M., Nudel I., Segev H., Mizraji G., Elnekave M., Furmanov K., et al. Langerhans cells down-regulate inflammation-driven alveolar bone loss. Proc Natl Acad Sci U S A 2012, 109:7043-7048.
3. Barbaroux J.B., Beleut M., Brisken C., Mueller C.G., Groves R.W. Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation. J Immunol 2008, 181:1103-1108.
4. Beristain A.G., Narala S.R., Di Grappa M.A., Khokha R. Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. J Cell Sci 2012, 125:943-955.
5. Cadet P., Rady P.L., Tyring S.K., Yandell R.B., Hughes T.K. Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol 1995, 173:25-29.
6. Elbe-Bürger A., Schuster C. Development of the prenatal cutaneous antigen-presenting cell network. Immunol Cell Biol 2010, 88:393-399.
7. Foster C.A., Holbrook K.A., Farr A.G. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants. J Invest Dermatol 1986, 86:240-243.
8. Fujita H., Nograles K.E., Kikuchi T., Gonzalez J., Carucci J.A., Krueger J.G. Human Langerhans cells induce distinct I.L-22-producing CD4+ cells lacking I.L-17 production. Proc Natl Acad Sci U S A 2009, 106:21795-21800.
9. Fujita M., Furukawa F., Horiguchi Y., Ueda M., Kashihara-Sawami M., Imamura S. Regional development of Langerhans cells and formation of Birbeck granules in human embryonic and fetal skin. J Invest Dermatol 1991, 97:65-72.
10. Furio L., Briotet I., Journeaux A., Billard H., Peguet-Navarro J. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells. J Invest Dermatol 2010, 130:1345-1354.
11. Hanada R., Hanada T., Sigl V., Schramek D., Penninger J.M. RANKL/RANK-beyond bones. J Mol Med (Berl) 2011, 89:647-656.
12. Huber C., Odermatt A., Hagmann B., Dahinden C.A., Fux M. In human basophils, IL-3 selectively induces RANKL expression that is modulated by IgER-dependent and -independent stimuli. Allergy 2014.
13. Kukita A., Kukita T. Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis. Future Oncol 2013, 9:1609-1622.
14. Leibbrandt A., Penninger J.M. RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 2008, 1143:123-150.
15. Loser K., Beissert S. Dendritic cells and T cells in the regulation of cutaneous immunity. Adv Dermatol 2007, 23:307-333.
16. Loser K., Mehling A., Loeser S., Apelt J., Kuhn A., Grabbe S., et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006, 12:1372-1379.
17. Mathers A.R., Janelsins B.M., Rubin J.P., Tkacheva O.A., Shufesky W.J., Watkins S.C., et al. Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol 2009, 182:921-933.
18. Michaelsson J., Mold J.E., McCune J.M., Nixon D.F. Regulation of T cell responses in the developing human fetus. J Immunol 2006, 176:5741-5748.
19. Schuster C., Mildner M., Mairhofer M., Bauer W., Fiala C., Prior M., et al. Human embryonic epidermis contains a diverse Langerhans cell precursor pool. Development 2014, 141:807-815.
20. + leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med 2009, 206:169-181.
21. Schuster C., Vaculik C., Prior M., Fiala C., Mildner M., Eppel W., et al. Phenotypic characterization of leukocytes in prenatal human dermis. J Invest Dermatol 2012, 132:2581-2592.
22. Seneschal J., Clark R.A., Gehad A., Baecher-Allan C.M., Kupper T.S. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 2012, 36:873-884.
23. Sigl V., Penninger J.M. RANKL/RANK - from bone physiology to breast cancer. Cytokine Growth Factor Rev 2014, 25:205-214.
24. Summers deLuca L., Gommerman J.L. Fine-tuning of dendritic cell biology by the TNF superfamily. Nat Rev Immunol 2012, 12:339-351.
25. bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 2008, 180:5737-5745.
26. Yamaguchi T., Sakaguchi S. Skin controls immune regulators. Nat Med 2006, 12:1358-1359.
27. Yasmin N., Bauer T., Modak M., Wagner K., Schuster C., Köffel R., et al. Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation. J Exp Med 2013, 210:2597-2610.